Our results also showed that 60.8% of patients with NPRL3-related epilepsy had drug-resistant epilepsy, consistent with the previous studies (6, 22), which may be due to the high occurrence of FCD among patients with neuroimaging abnormalities (6). Here, NPRL3 is linked to epilepsy.